Sign In

Login

Password

Forgot Password ? Sign Up

Interleukin-17 (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Interleukin-17" in German language version.

refsWebsite
Global rank German rank
43doi.org
2nd place
3rd place
43nih.gov
4th place
7th place
9zdb-katalog.de
123rd place
6th place
4jimmunol.org
low place
low place
3europa.eu
68th place
29th place
2bmj.com
1,226th place
1,116th place
1plos.org
2,112th place
1,609th place
1lww.com
2,769th place
2,484th place
1harvard.edu
18th place
181st place
1escholarship.org
1,523rd place
4,348th place
1drugs.com
399th place
3,700th place
1pharmazeutische-zeitung.de
8,614th place
583rd place

bmj.com (Global: 1,226th place; German: 1,116th place)

ard.bmj.com

  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).
  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).

doi.org (Global: 2nd place; German: 3rd place)

  • S. G. Hymowitz, E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, G. Pan, A. L. Gurney, A. M. de Vos, M. A. Starovasnik: IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. In: The EMBO Journal. Band 20, Nr. 19, Oktober 2001, S. 5332–5341, doi:10.1093/emboj/20.19.5332, PMID 11574464, PMC 125646 (freier Volltext).
  • T. A. Moseley, D. R. Haudenschild, L. Rose, A. H. Reddi: Interleukin-17 family and IL-17 receptors. In: Cytokine & Growth Factor Reviews. Band 14, Nr. 2, April 2003, S. 155–174, doi:10.1016/S1359-6101(03)00002-9, PMID 12651226.
  • S. Aggarwal, N. Ghilardi, M. H. Xie, F. J. de Sauvage, A. L. Gurney: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. In: The Journal of Biological Chemistry. Band 278, Nr. 3, Januar 2003, S. 1910–1914, doi:10.1074/jbc.M207577200, PMID 12417590.
  • T. Starnes, H. E. Broxmeyer, M. J. Robertson, R. Hromas: Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. In: Journal of Immunology. Band 169, Nr. 2, Juli 2002, S. 642–646, doi:10.4049/jimmunol.169.2.642, PMID 12097364 (jimmunol.org).
  • Myew-Ling Toh, Gaelle Gonzales, Marije I. Koenders, Anne Tournadre, David Boyle: Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression. In: PLoS ONE. Band 5, Nr. 10, 15. Oktober 2010, ISSN 1932-6203, Artikel e13416, doi:10.1371/journal.pone.0013416, PMID 20976214, PMC 2955522 (freier Volltext) – (plos.org [abgerufen am 13. September 2021]).
  • M. Kawaguchi, F. Kokubu, J. Fujita, S. K. Huang, N. Hizawa: Role of interleukin-17F in asthma. In: Inflammation & Allergy Drug Targets. Band 8, Nr. 5, Dezember 2009, S. 383–389, doi:10.2174/1871528110908050383, PMID 20025586.
  • D. A. Martin, J. E. Towne, G. Kricorian, P. Klekotka, J. E. Gudjonsson, J. G. Krueger, C. B. Russell: The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. In: The Journal of Investigative Dermatology. Band 133, Nr. 1, Januar 2013, S. 17–26, doi:10.1038/jid.2012.194, PMID 22673731, PMC 3568997 (freier Volltext).
  • M. A. Lowes, M. Suárez-Fariñas, J. G. Krueger: Immunology of psoriasis. In: Annual Review of Immunology. Band 32, 2014, S. 227–255, doi:10.1146/annurev-immunol-032713-120225, PMID 24655295, PMC 4229247 (freier Volltext).
  • Stephan R Targan, Brian Feagan, Severine Vermeire, Remo Panaccione, Gil Y Melmed: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease. In: American Journal of Gastroenterology. Band 111, Nr. 11, November 2016, ISSN 0002-9270, S. 1599–1607, doi:10.1038/ajg.2016.298 (lww.com [abgerufen am 13. September 2021]).
  • C. Johansen, P. A. Usher, R. B. Kjellerup, D. Lundsgaard, L. Iversen, K. Kragballe: Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. In: The British Journal of Dermatology. Band 160, Nr. 2, Februar 2009, S. 319–24, doi:10.1111/j.1365-2133.2008.08902.x, PMID 19016708.
  • J. K. Kolls, A. Lindén: Interleukin-17 family members and inflammation. In: Immunity. Band 21, Nr. 4, Oktober 2004, S. 467–476, doi:10.1016/j.immuni.2004.08.018, PMID 15485625.
  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).
  • M. Kawaguchi, M. Adachi, N. Oda, F. Kokubu, S. K. Huang: IL-17 cytokine family. In: The Journal of Allergy and Clinical Immunology. Band 114, Nr. 6, Dezember 2004, S. 1265–1273; quiz 1274, doi:10.1016/j.jaci.2004.10.019, PMID 15577820.
  • R. Pappu, V. Ramirez-Carrozzi, A. Sambandam: The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. In: Immunology. Band 134, Nr. 1, September 2011, S. 8–16, doi:10.1111/j.1365-2567.2011.03465.x, PMID 21726218, PMC 3173690 (freier Volltext).
  • K. Ley, E. Smith, M. A. Stark: IL-17A-producing neutrophil-regulatory Tn lymphocytes. In: Immunologic Research. Band 34, Nr. 3, 2006, S. 229–242, doi:10.1385/IR:34:3:229, PMID 16891673.
  • A. Chiricozzi, E. Guttman-Yassky, M. Suárez-Fariñas, K. E. Nograles, S. Tian, I. Cardinale, S. Chimenti, J. G. Krueger: Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. In: The journal of Investigative Dermatology. Band 131, Nr. 3, März 2011, S. 677–687, doi:10.1038/jid.2010.340, PMID 21085185.
  • P. Miossec, T. Korn, V. K. Kuchroo: Interleukin-17 and type 17 helper T cells. In: The New England Journal of Medicine. Band 361, Nr. 9, August 2009, S. 888–898, doi:10.1056/NEJMra0707449, PMID 19710487.
  • S. H. Chang, Y. Chung, C. Dong: Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. In: The Journal of Biological Chemistry. Band 285, Nr. 50, Dezember 2010, S. 38751–38755, doi:10.1074/jbc.C110.185777, PMID 20974859, PMC 2998156 (freier Volltext).
  • M. L. Cho, J. W. Kang, Y. M. Moon, H. J. Nam, J. Y. Jhun, S. B. Heo, H. T. Jin, S. Y. Min, J. H. Ju, K. S. Park, Y. G. Cho, C. H. Yoon, S. H. Park, Y. C. Sung, H. Y. Kim: STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. In: Journal of Immunology. Band 176, Nr. 9, Mai 2006, S. 5652–5661, doi:10.4049/jimmunol.176.9.5652, PMID 16622035 (jimmunol.org).
  • Z. Chen, A. Laurence, Y. Kanno, M. Pacher-Zavisin, B. M. Zhu, C. Tato, A. Yoshimura, L. Hennighausen, J. J. O’Shea: Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. In: Proceedings of the National Academy of Sciences of the United States of America. Band 103, Nr. 21, Mai 2006, S. 8137–8142, doi:10.1073/pnas.0600666103, PMID 16698929, PMC 1459629 (freier Volltext), bibcode:2006PNAS..103.8137C.
  • M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, B. Stockinger: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. In: Immunity. Band 24, Nr. 2, Februar 2006, S. 179–189, doi:10.1016/j.immuni.2006.01.001, PMID 16473830.
  • P. R. Mangan, L. E. Harrington, D. B. O’Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, C. T. Weaver: Transforming growth factor-beta induces development of the T(H)17 lineage. In: Nature. Band 441, Nr. 7090, Mai 2006, S. 231–234, doi:10.1038/nature04754, PMID 16648837.
  • E. Bettelli, Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, V. K. Kuchroo: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. In: Nature. Band 441, Nr. 7090, Mai 2006, S. 235–238, doi:10.1038/nature04753, PMID 16648838.
  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).
  • I. I. Ivanov, B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, D. R. Littman: The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. In: Cell. Band 126, Nr. 6, September 2006, S. 1121–1133, doi:10.1016/j.cell.2006.07.035, PMID 16990136.
  • H. Zhu, Z. Wang, J. Yu, X. Yang, F. He, Z. Liu, F. Che, X. Chen, H. Ren, M. Hong, J. Wang: Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. In: Progress in Neurobiology. Band 178, Juli 2019, S. 101610, doi:10.1016/j.pneurobio.2019.03.003, PMID 30923023.
  • Y. Hu, F. Shen, N. K. Crellin, W. Ouyang: The IL-17 pathway as a major therapeutic target in autoimmune diseases. In: Annals of the New York Academy of Sciences. Band 1217, Nr. 1, Januar 2011, S. 60–76, doi:10.1111/j.1749-6632.2010.05825.x, PMID 21155836.
  • J. Baliwag, D. H. Barnes, A. Johnston: Cytokines in psoriasis. In: Cytokine. Band 73, Nr. 2, Juni 2015, S. 342–350, doi:10.1016/j.cyto.2014.12.014, PMID 25585875, PMC 4437803 (freier Volltext).
  • P. Mudigonda, T. Mudigonda, A. N. Feneran, H. S. Alamdari, L. Sandoval, S. R. Feldman: Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. In: Dermatology Online Journal. Band 18, Nr. 10, Oktober 2012, S. 1, doi:10.5070/D33N39N8XM, PMID 23122008 (escholarship.org).
  • A. M. Lin, C. J. Rubin, R. Khandpur, J. Y. Wang, M. Riblett, S. Yalavarthi, E. C. Villanueva, P. Shah, M. J. Kaplan, A. T. Bruce: Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. In: Journal of Immunology. Band 187, Nr. 1, Juli 2011, S. 490–500, doi:10.4049/jimmunol.1100123, PMID 21606249, PMC 3119764 (freier Volltext).
  • K. Nakajima, T. Kanda, M. Takaishi, T. Shiga, K. Miyoshi, H. Nakajima, R. Kamijima, M. Tarutani, J. M. Benson, M. M. Elloso, L. L. Gutshall, M. F. Naso, Y. Iwakura, J. DiGiovanni, S. Sano: Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. In: Journal of Immunology. Band 186, Nr. 7, April 2011, S. 4481–4489, doi:10.4049/jimmunol.1000148, PMID 21346238.
  • J. G. Krueger, S. Fretzin, M. Suárez-Fariñas, P. A. Haslett, K. M. Phipps, G. S. Cameron, J. McColm, A. Katcherian, I. Cueto, T. White, S. Banerjee, R. W. Hoffman: IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. In: The Journal of Allergy and Clinical Immunology. Band 130, Nr. 1, Juli 2012, S. 145–154.e9, doi:10.1016/j.jaci.2012.04.024, PMID 22677045, PMC 3470466 (freier Volltext).
  • Y. Dombrowski, J. Schauber: Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis. In: Experimental Dermatology. Band 21, Nr. 5, Mai 2012, S. 327–330, doi:10.1111/j.1600-0625.2012.01459.x, PMID 22509827.
  • S. Nischwitz, H. Faber, P. G. Sämann, H. S. Domingues, G. Krishnamoorthy: Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients. In: Acta Neurologica Scandinavica. Band 130, Nr. 1, Juli 2014, ISSN 1600-0404, S. 46–52, doi:10.1111/ane.12215, PMID 24571587.
  • W. Swardfager, D. A. Winer, N. Herrmann, S. Winer, K. L. Lanctôt: Interleukin-17 in post-stroke neurodegeneration. In: Neuroscience and Biobehavioral Reviews. Band 37, Nr. 3, März 2013, S. 436–447, doi:10.1016/j.neubiorev.2013.01.021, PMID 23370232.
  • M. L. Ortiz, V. Kumar, A. Martner, S. Mony, L. Donthireddy, T. Condamine, J. Seykora, S. C. Knight, G. Malietzis, G. H. Lee, M. Moorghen, B. Lenox, N. Luetteke, E. Celis, D. Gabrilovich: Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. In: The Journal of Experimental Medicine. Band 212, Nr. 3, März 2015, S. 351–367, doi:10.1084/jem.20140835, PMID 25667306, PMC 4354367 (freier Volltext).
  • F. Carbonell, H. Heimpel, B. Kubanek, T. M. Fliedner: Growth and cytogenetic characteristics of bone marrow colonies from patients with 5q-syndrome. In: Blood. Band 66, Nr. 2, August 1985, S. 463–465, doi:10.1182/blood.V66.2.463.463, PMID 4016279.
  • Hartwig Cleve, R. L. Kirk, D. C. Gajdusek, J. Guiart: On the distribution of the Gc variant Gc Aborigine in Melanesian populations; determination of Gc-types in sera from Tongariki Island, New Hebrides. In: Acta Genetica et Statistica Medica. Band 17, Nr. 6, 1967, S. 511–517, doi:10.1159/000152104, PMID 4168861.
  • M. Seppälä, L. Rönnberg, S. L. Karonen, A. Kauppila: Micronized oral progesterone increases the circulating level of endometrial secretory PP14/beta-lactoglobulin homologue. In: Human Reproduction. Band 2, Nr. 6, August 1987, S. 453–455, doi:10.1093/oxfordjournals.humrep.a136569, PMID 3312283.
  • Kenneth B. Gordon, Andrew Blauvelt, Kim A. Papp, Richard G. Langley, Thomas Luger: Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. In: New England Journal of Medicine. Band 375, Nr. 4, 28. Juli 2016, ISSN 0028-4793, S. 345–356, doi:10.1056/NEJMoa1512711.
  • Richard B. Warren, Andrew Blauvelt, Jerry Bagel, Kim A. Papp, Paul Yamauchi: Bimekizumab versus Adalimumab in Plaque Psoriasis. In: New England Journal of Medicine. Band 385, Nr. 2, 8. Juli 2021, ISSN 0028-4793, S. 130–141, doi:10.1056/NEJMoa2102388.
  • Philip J. Mease, Mark C. Genovese, Maria W. Greenwald, Christopher T. Ritchlin, André D. Beaulieu: Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis. In: New England Journal of Medicine. Band 370, Nr. 24, 12. Juni 2014, ISSN 0028-4793, S. 2295–2306, doi:10.1056/NEJMoa1315231.
  • C. L. Leonardi, A. B. Kimball, K. A. Papp, N. Yeilding, C. Guzzo, Y. Wang, S. Li, L. T. Dooley, K. B. Gordon: Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). In: The Lancet. Band 371, Nr. 9625, Mai 2008, S. 1665–1674, doi:10.1016/S0140-6736(08)60725-4, PMID 18486739.

drugs.com (Global: 399th place; German: 3,700th place)

escholarship.org (Global: 1,523rd place; German: 4,348th place)

  • P. Mudigonda, T. Mudigonda, A. N. Feneran, H. S. Alamdari, L. Sandoval, S. R. Feldman: Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. In: Dermatology Online Journal. Band 18, Nr. 10, Oktober 2012, S. 1, doi:10.5070/D33N39N8XM, PMID 23122008 (escholarship.org).

europa.eu (Global: 68th place; German: 29th place)

ema.europa.eu

harvard.edu (Global: 18th place; German: 181st place)

ui.adsabs.harvard.edu

  • Z. Chen, A. Laurence, Y. Kanno, M. Pacher-Zavisin, B. M. Zhu, C. Tato, A. Yoshimura, L. Hennighausen, J. J. O’Shea: Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. In: Proceedings of the National Academy of Sciences of the United States of America. Band 103, Nr. 21, Mai 2006, S. 8137–8142, doi:10.1073/pnas.0600666103, PMID 16698929, PMC 1459629 (freier Volltext), bibcode:2006PNAS..103.8137C.

jimmunol.org (Global: low place; German: low place)

  • T. Starnes, H. E. Broxmeyer, M. J. Robertson, R. Hromas: Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. In: Journal of Immunology. Band 169, Nr. 2, Juli 2002, S. 642–646, doi:10.4049/jimmunol.169.2.642, PMID 12097364 (jimmunol.org).
  • E. Rouvier, M. F. Luciani, M. G. Mattéi, F. Denizot, P. Golstein: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. In: Journal of Immunology. Band 150, Nr. 12, Juni 1993, S. 5445–56, PMID 8390535 (jimmunol.org).
  • Z. Yao, S. L. Painter, W. C. Fanslow, D. Ulrich, B. M. Macduff, M. K. Spriggs, R. J. Armitage: Human IL-17: a novel cytokine derived from T cells. In: Journal of Immunology. Band 155, Nr. 12, Dezember 1995, S. 5483–5486, PMID 7499828 (jimmunol.org).
  • M. L. Cho, J. W. Kang, Y. M. Moon, H. J. Nam, J. Y. Jhun, S. B. Heo, H. T. Jin, S. Y. Min, J. H. Ju, K. S. Park, Y. G. Cho, C. H. Yoon, S. H. Park, Y. C. Sung, H. Y. Kim: STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. In: Journal of Immunology. Band 176, Nr. 9, Mai 2006, S. 5652–5661, doi:10.4049/jimmunol.176.9.5652, PMID 16622035 (jimmunol.org).

lww.com (Global: 2,769th place; German: 2,484th place)

journals.lww.com

  • Stephan R Targan, Brian Feagan, Severine Vermeire, Remo Panaccione, Gil Y Melmed: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease. In: American Journal of Gastroenterology. Band 111, Nr. 11, November 2016, ISSN 0002-9270, S. 1599–1607, doi:10.1038/ajg.2016.298 (lww.com [abgerufen am 13. September 2021]).

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • S. G. Hymowitz, E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, G. Pan, A. L. Gurney, A. M. de Vos, M. A. Starovasnik: IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. In: The EMBO Journal. Band 20, Nr. 19, Oktober 2001, S. 5332–5341, doi:10.1093/emboj/20.19.5332, PMID 11574464, PMC 125646 (freier Volltext).
  • T. A. Moseley, D. R. Haudenschild, L. Rose, A. H. Reddi: Interleukin-17 family and IL-17 receptors. In: Cytokine & Growth Factor Reviews. Band 14, Nr. 2, April 2003, S. 155–174, doi:10.1016/S1359-6101(03)00002-9, PMID 12651226.
  • S. Aggarwal, N. Ghilardi, M. H. Xie, F. J. de Sauvage, A. L. Gurney: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. In: The Journal of Biological Chemistry. Band 278, Nr. 3, Januar 2003, S. 1910–1914, doi:10.1074/jbc.M207577200, PMID 12417590.
  • T. Starnes, H. E. Broxmeyer, M. J. Robertson, R. Hromas: Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. In: Journal of Immunology. Band 169, Nr. 2, Juli 2002, S. 642–646, doi:10.4049/jimmunol.169.2.642, PMID 12097364 (jimmunol.org).
  • Myew-Ling Toh, Gaelle Gonzales, Marije I. Koenders, Anne Tournadre, David Boyle: Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression. In: PLoS ONE. Band 5, Nr. 10, 15. Oktober 2010, ISSN 1932-6203, Artikel e13416, doi:10.1371/journal.pone.0013416, PMID 20976214, PMC 2955522 (freier Volltext) – (plos.org [abgerufen am 13. September 2021]).
  • M. Kawaguchi, F. Kokubu, J. Fujita, S. K. Huang, N. Hizawa: Role of interleukin-17F in asthma. In: Inflammation & Allergy Drug Targets. Band 8, Nr. 5, Dezember 2009, S. 383–389, doi:10.2174/1871528110908050383, PMID 20025586.
  • D. A. Martin, J. E. Towne, G. Kricorian, P. Klekotka, J. E. Gudjonsson, J. G. Krueger, C. B. Russell: The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. In: The Journal of Investigative Dermatology. Band 133, Nr. 1, Januar 2013, S. 17–26, doi:10.1038/jid.2012.194, PMID 22673731, PMC 3568997 (freier Volltext).
  • M. A. Lowes, M. Suárez-Fariñas, J. G. Krueger: Immunology of psoriasis. In: Annual Review of Immunology. Band 32, 2014, S. 227–255, doi:10.1146/annurev-immunol-032713-120225, PMID 24655295, PMC 4229247 (freier Volltext).
  • C. Johansen, P. A. Usher, R. B. Kjellerup, D. Lundsgaard, L. Iversen, K. Kragballe: Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. In: The British Journal of Dermatology. Band 160, Nr. 2, Februar 2009, S. 319–24, doi:10.1111/j.1365-2133.2008.08902.x, PMID 19016708.
  • E. Rouvier, M. F. Luciani, M. G. Mattéi, F. Denizot, P. Golstein: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. In: Journal of Immunology. Band 150, Nr. 12, Juni 1993, S. 5445–56, PMID 8390535 (jimmunol.org).
  • J. K. Kolls, A. Lindén: Interleukin-17 family members and inflammation. In: Immunity. Band 21, Nr. 4, Oktober 2004, S. 467–476, doi:10.1016/j.immuni.2004.08.018, PMID 15485625.
  • Z. Yao, S. L. Painter, W. C. Fanslow, D. Ulrich, B. M. Macduff, M. K. Spriggs, R. J. Armitage: Human IL-17: a novel cytokine derived from T cells. In: Journal of Immunology. Band 155, Nr. 12, Dezember 1995, S. 5483–5486, PMID 7499828 (jimmunol.org).
  • S. Aggarwal, A. L. Gurney: IL-17: prototype member of an emerging cytokine family. In: Journal of Leukocyte Biology. Band 71, Nr. 1, Januar 2002, S. 1–8, PMID 11781375.
  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).
  • M. Kawaguchi, M. Adachi, N. Oda, F. Kokubu, S. K. Huang: IL-17 cytokine family. In: The Journal of Allergy and Clinical Immunology. Band 114, Nr. 6, Dezember 2004, S. 1265–1273; quiz 1274, doi:10.1016/j.jaci.2004.10.019, PMID 15577820.
  • R. Pappu, V. Ramirez-Carrozzi, A. Sambandam: The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. In: Immunology. Band 134, Nr. 1, September 2011, S. 8–16, doi:10.1111/j.1365-2567.2011.03465.x, PMID 21726218, PMC 3173690 (freier Volltext).
  • K. Ley, E. Smith, M. A. Stark: IL-17A-producing neutrophil-regulatory Tn lymphocytes. In: Immunologic Research. Band 34, Nr. 3, 2006, S. 229–242, doi:10.1385/IR:34:3:229, PMID 16891673.
  • A. Chiricozzi, E. Guttman-Yassky, M. Suárez-Fariñas, K. E. Nograles, S. Tian, I. Cardinale, S. Chimenti, J. G. Krueger: Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. In: The journal of Investigative Dermatology. Band 131, Nr. 3, März 2011, S. 677–687, doi:10.1038/jid.2010.340, PMID 21085185.
  • P. Miossec, T. Korn, V. K. Kuchroo: Interleukin-17 and type 17 helper T cells. In: The New England Journal of Medicine. Band 361, Nr. 9, August 2009, S. 888–898, doi:10.1056/NEJMra0707449, PMID 19710487.
  • M. Awane, P. G. Andres, D. J. Li, H. C. Reinecker: NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. In: Journal of Immunology. Band 162, Nr. 9, 1. Mai 1999, ISSN 0022-1767, S. 5337–5344, PMID 10228009.
  • S. H. Chang, Y. Chung, C. Dong: Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. In: The Journal of Biological Chemistry. Band 285, Nr. 50, Dezember 2010, S. 38751–38755, doi:10.1074/jbc.C110.185777, PMID 20974859, PMC 2998156 (freier Volltext).
  • M. L. Cho, J. W. Kang, Y. M. Moon, H. J. Nam, J. Y. Jhun, S. B. Heo, H. T. Jin, S. Y. Min, J. H. Ju, K. S. Park, Y. G. Cho, C. H. Yoon, S. H. Park, Y. C. Sung, H. Y. Kim: STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. In: Journal of Immunology. Band 176, Nr. 9, Mai 2006, S. 5652–5661, doi:10.4049/jimmunol.176.9.5652, PMID 16622035 (jimmunol.org).
  • Z. Chen, A. Laurence, Y. Kanno, M. Pacher-Zavisin, B. M. Zhu, C. Tato, A. Yoshimura, L. Hennighausen, J. J. O’Shea: Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. In: Proceedings of the National Academy of Sciences of the United States of America. Band 103, Nr. 21, Mai 2006, S. 8137–8142, doi:10.1073/pnas.0600666103, PMID 16698929, PMC 1459629 (freier Volltext), bibcode:2006PNAS..103.8137C.
  • M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, B. Stockinger: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. In: Immunity. Band 24, Nr. 2, Februar 2006, S. 179–189, doi:10.1016/j.immuni.2006.01.001, PMID 16473830.
  • P. R. Mangan, L. E. Harrington, D. B. O’Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, C. T. Weaver: Transforming growth factor-beta induces development of the T(H)17 lineage. In: Nature. Band 441, Nr. 7090, Mai 2006, S. 231–234, doi:10.1038/nature04754, PMID 16648837.
  • E. Bettelli, Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, V. K. Kuchroo: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. In: Nature. Band 441, Nr. 7090, Mai 2006, S. 235–238, doi:10.1038/nature04753, PMID 16648838.
  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).
  • I. I. Ivanov, B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, D. R. Littman: The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. In: Cell. Band 126, Nr. 6, September 2006, S. 1121–1133, doi:10.1016/j.cell.2006.07.035, PMID 16990136.
  • H. Zhu, Z. Wang, J. Yu, X. Yang, F. He, Z. Liu, F. Che, X. Chen, H. Ren, M. Hong, J. Wang: Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. In: Progress in Neurobiology. Band 178, Juli 2019, S. 101610, doi:10.1016/j.pneurobio.2019.03.003, PMID 30923023.
  • Y. Hu, F. Shen, N. K. Crellin, W. Ouyang: The IL-17 pathway as a major therapeutic target in autoimmune diseases. In: Annals of the New York Academy of Sciences. Band 1217, Nr. 1, Januar 2011, S. 60–76, doi:10.1111/j.1749-6632.2010.05825.x, PMID 21155836.
  • J. Baliwag, D. H. Barnes, A. Johnston: Cytokines in psoriasis. In: Cytokine. Band 73, Nr. 2, Juni 2015, S. 342–350, doi:10.1016/j.cyto.2014.12.014, PMID 25585875, PMC 4437803 (freier Volltext).
  • P. Mudigonda, T. Mudigonda, A. N. Feneran, H. S. Alamdari, L. Sandoval, S. R. Feldman: Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. In: Dermatology Online Journal. Band 18, Nr. 10, Oktober 2012, S. 1, doi:10.5070/D33N39N8XM, PMID 23122008 (escholarship.org).
  • A. M. Lin, C. J. Rubin, R. Khandpur, J. Y. Wang, M. Riblett, S. Yalavarthi, E. C. Villanueva, P. Shah, M. J. Kaplan, A. T. Bruce: Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. In: Journal of Immunology. Band 187, Nr. 1, Juli 2011, S. 490–500, doi:10.4049/jimmunol.1100123, PMID 21606249, PMC 3119764 (freier Volltext).
  • K. Nakajima, T. Kanda, M. Takaishi, T. Shiga, K. Miyoshi, H. Nakajima, R. Kamijima, M. Tarutani, J. M. Benson, M. M. Elloso, L. L. Gutshall, M. F. Naso, Y. Iwakura, J. DiGiovanni, S. Sano: Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. In: Journal of Immunology. Band 186, Nr. 7, April 2011, S. 4481–4489, doi:10.4049/jimmunol.1000148, PMID 21346238.
  • J. G. Krueger, S. Fretzin, M. Suárez-Fariñas, P. A. Haslett, K. M. Phipps, G. S. Cameron, J. McColm, A. Katcherian, I. Cueto, T. White, S. Banerjee, R. W. Hoffman: IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. In: The Journal of Allergy and Clinical Immunology. Band 130, Nr. 1, Juli 2012, S. 145–154.e9, doi:10.1016/j.jaci.2012.04.024, PMID 22677045, PMC 3470466 (freier Volltext).
  • Y. Dombrowski, J. Schauber: Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis. In: Experimental Dermatology. Band 21, Nr. 5, Mai 2012, S. 327–330, doi:10.1111/j.1600-0625.2012.01459.x, PMID 22509827.
  • S. Nischwitz, H. Faber, P. G. Sämann, H. S. Domingues, G. Krishnamoorthy: Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients. In: Acta Neurologica Scandinavica. Band 130, Nr. 1, Juli 2014, ISSN 1600-0404, S. 46–52, doi:10.1111/ane.12215, PMID 24571587.
  • W. Swardfager, D. A. Winer, N. Herrmann, S. Winer, K. L. Lanctôt: Interleukin-17 in post-stroke neurodegeneration. In: Neuroscience and Biobehavioral Reviews. Band 37, Nr. 3, März 2013, S. 436–447, doi:10.1016/j.neubiorev.2013.01.021, PMID 23370232.
  • M. L. Ortiz, V. Kumar, A. Martner, S. Mony, L. Donthireddy, T. Condamine, J. Seykora, S. C. Knight, G. Malietzis, G. H. Lee, M. Moorghen, B. Lenox, N. Luetteke, E. Celis, D. Gabrilovich: Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. In: The Journal of Experimental Medicine. Band 212, Nr. 3, März 2015, S. 351–367, doi:10.1084/jem.20140835, PMID 25667306, PMC 4354367 (freier Volltext).
  • F. Carbonell, H. Heimpel, B. Kubanek, T. M. Fliedner: Growth and cytogenetic characteristics of bone marrow colonies from patients with 5q-syndrome. In: Blood. Band 66, Nr. 2, August 1985, S. 463–465, doi:10.1182/blood.V66.2.463.463, PMID 4016279.
  • Hartwig Cleve, R. L. Kirk, D. C. Gajdusek, J. Guiart: On the distribution of the Gc variant Gc Aborigine in Melanesian populations; determination of Gc-types in sera from Tongariki Island, New Hebrides. In: Acta Genetica et Statistica Medica. Band 17, Nr. 6, 1967, S. 511–517, doi:10.1159/000152104, PMID 4168861.
  • M. Seppälä, L. Rönnberg, S. L. Karonen, A. Kauppila: Micronized oral progesterone increases the circulating level of endometrial secretory PP14/beta-lactoglobulin homologue. In: Human Reproduction. Band 2, Nr. 6, August 1987, S. 453–455, doi:10.1093/oxfordjournals.humrep.a136569, PMID 3312283.
  • C. L. Leonardi, A. B. Kimball, K. A. Papp, N. Yeilding, C. Guzzo, Y. Wang, S. Li, L. T. Dooley, K. B. Gordon: Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). In: The Lancet. Band 371, Nr. 9625, Mai 2008, S. 1665–1674, doi:10.1016/S0140-6736(08)60725-4, PMID 18486739.

pharmazeutische-zeitung.de (Global: 8,614th place; German: 583rd place)

plos.org (Global: 2,112th place; German: 1,609th place)

dx.plos.org

  • Myew-Ling Toh, Gaelle Gonzales, Marije I. Koenders, Anne Tournadre, David Boyle: Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression. In: PLoS ONE. Band 5, Nr. 10, 15. Oktober 2010, ISSN 1932-6203, Artikel e13416, doi:10.1371/journal.pone.0013416, PMID 20976214, PMC 2955522 (freier Volltext) – (plos.org [abgerufen am 13. September 2021]).

zdb-katalog.de (Global: 123rd place; German: 6th place)

  • Myew-Ling Toh, Gaelle Gonzales, Marije I. Koenders, Anne Tournadre, David Boyle: Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression. In: PLoS ONE. Band 5, Nr. 10, 15. Oktober 2010, ISSN 1932-6203, Artikel e13416, doi:10.1371/journal.pone.0013416, PMID 20976214, PMC 2955522 (freier Volltext) – (plos.org [abgerufen am 13. September 2021]).
  • Stephan R Targan, Brian Feagan, Severine Vermeire, Remo Panaccione, Gil Y Melmed: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease. In: American Journal of Gastroenterology. Band 111, Nr. 11, November 2016, ISSN 0002-9270, S. 1599–1607, doi:10.1038/ajg.2016.298 (lww.com [abgerufen am 13. September 2021]).
  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).
  • M. Awane, P. G. Andres, D. J. Li, H. C. Reinecker: NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. In: Journal of Immunology. Band 162, Nr. 9, 1. Mai 1999, ISSN 0022-1767, S. 5337–5344, PMID 10228009.
  • Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. In: Annals of the Rheumatic Diseases. Band 77, Nr. 4, April 2018, ISSN 0003-4967, S. 523–532, doi:10.1136/annrheumdis-2017-212127, PMID 29275332, PMC 5890624 (freier Volltext) – (bmj.com [abgerufen am 13. September 2021]).
  • S. Nischwitz, H. Faber, P. G. Sämann, H. S. Domingues, G. Krishnamoorthy: Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients. In: Acta Neurologica Scandinavica. Band 130, Nr. 1, Juli 2014, ISSN 1600-0404, S. 46–52, doi:10.1111/ane.12215, PMID 24571587.
  • Kenneth B. Gordon, Andrew Blauvelt, Kim A. Papp, Richard G. Langley, Thomas Luger: Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. In: New England Journal of Medicine. Band 375, Nr. 4, 28. Juli 2016, ISSN 0028-4793, S. 345–356, doi:10.1056/NEJMoa1512711.
  • Richard B. Warren, Andrew Blauvelt, Jerry Bagel, Kim A. Papp, Paul Yamauchi: Bimekizumab versus Adalimumab in Plaque Psoriasis. In: New England Journal of Medicine. Band 385, Nr. 2, 8. Juli 2021, ISSN 0028-4793, S. 130–141, doi:10.1056/NEJMoa2102388.
  • Philip J. Mease, Mark C. Genovese, Maria W. Greenwald, Christopher T. Ritchlin, André D. Beaulieu: Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis. In: New England Journal of Medicine. Band 370, Nr. 24, 12. Juni 2014, ISSN 0028-4793, S. 2295–2306, doi:10.1056/NEJMoa1315231.